Logo
Website CRS  >  Search
Search
    Search for:
     

    Advanced search

    Rules:

    Only words with 2 or more characters are accepted
    Max 200 chars total
    Space is used to split words, "" can be used to search for a whole string (not indexed search then)
    AND, OR and NOT are prefix words, overruling the default operator
    +/|/- equals AND, OR and NOT as operators.
    All search words are converted to lowercase.

    Search for "therapy"

    Displaying results 1 to 6 out of 6

      2000 – 2009 81%
      ... 30-Dezember 3, 2008 Baumann S . Sublingual immunotherapy (SLIT) adjuvanted with monophosphoryl lipid A (MPL®): ... of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Arch Dermatol Res. 2008 Feb; ... S , Woroniecki SR, Klimek L. Sublingual immunotherapy adjuvanted with monophosphoryl lipid A: preliminary ... K , Burkhard-Meier C, Gülker H, Horlitz M. Curative
      Size: 53 K - Created: 09-11-15 - Modified: 14-12-18 17:16
    Path: /Expertise/Published Expertise/2000 – 2009

      Pharmacodynamic Expertise 80%
      ... is the key benefit of biomarkers. Due to changes in biomarker patterns it is possible to distinguish between effective and ineffective drug therapy, which enables “go/no-go” decisions for the clinical drug development programmes of our clients combined with time and cost savings. CRS has ...
      Size: 35 K - Created: 18-11-12 - Modified: 14-12-18 17:16
    Path: /Expertise/Pharmacodynamic Expertise

      Trial Expertise 76%
      ... conducts various trials in this field to support the increase of beneficial effects and to enhance the prevention of negative effects from drug therapy. Because genetic factors affect human responses to therapeutic drugs, CRS has access to a broad range of genotyped subjects . Thorough ...
      Size: 35 K - Created: 18-11-12 - Modified: 14-12-18 17:16
    Path: /Expertise/Trial Expertise

      1990 – 1999 75%
      ... activity of monophosphoryl lipid A in specific immunotherapy. J Clin Pharmacol 1999 ; 39(9):No. 47. Rensing UF, ... as a parameter of bioavailability of oral magnesium therapy. Methods Find Exp Clin Pharmacol. 1992 May; ... of Therpeutic Availability of Oral Magnesium Therapy. Poster, 13. Bobenheimer Allerheiligengespräch, ... R, editors. Pharmacological basis of cholinergic
      Size: 61 K - Created: 18-11-12 - Modified: 14-12-18 17:16
    Path: /Expertise/Published Expertise/1990 – 1999

      1981 – 1989 69%
      ... M, Zeidler H, König J, Kirch W. Double-blind study on the interaction of oxaprozin with metoprolol in hypertensives. Cardiovascular Drugs and Therapy 1989 ; 3: 441-443. Halabi A , Zurborn KH, Kaiser P, Proppe D, Kirch W. Haemostaseological parameters and circadian blood pressure values in ...
      Size: 41 K - Created: 18-11-12 - Modified: 14-12-18 17:16
    Path: /Expertise/Published Expertise/1981 – 1989

      2010-2018 68%
      ... M, Teschler H, Vogelmeier C, Janciauskiene S, Koczulla AR The effects of weekly augmentation therapy in patients with PiZZ ?1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis. ... Infusions in Healthy Volunteers - Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago, USAChemo
      Size: 66 K - Created: 09-11-15 - Modified: 14-12-18 17:16
    Path: /Expertise/Published Expertise/2010-2018

    Callback
    FooterEnd